ARCHIVES

“Treatment INDs” Seen As Major Threat To Clinical Trials

This article is from The Cancer Letter archive.

Vol. 13 No. 34 | August 21, 1987

Download PDF Visit The Full Archive

Related Articles

Reports of SPOREs cut Premature, Broder Says, Wait for Peer Review

March 13, 1992

Minority CCOP Applications Not Yet Reviewed

December 15, 1989

NIC Grants Appeals Process Explained

April 19, 1985

Professional Societies: Three Groups To File brief In Fisher’s Appeal

October 11, 1996

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

November 15, 2013

Capitol Hill: Trial Results Represent Culmination of Research, Klausner Tells House

March 19, 1999